文献速递甲状腺核医学肿瘤 PET/CT

18F-氟胆碱PET/CT提示15岁患者HPT-JT综合征伴活动性颌骨骨化纤维瘤

[18F]Fluorocholine PET/CT in a 15-year-old patient suggested HPT-JT syndrome with active cemento-ossifying fibroma.
PubMed 文献 · EJNMMI Res · 2026-01-14

本文报道一例15岁男性严重高钙血症、PTH升高且有颌骨骨化纤维瘤切除史的患者,99mTc-MIBI显像不能明确诊断,18F-氟胆碱PET/CT成功定位功能亢进的甲状旁腺(病理为甲状旁腺非典型腺瘤)及复发性上颌骨骨化纤维瘤,基因检测证实CDC73突变而确诊HPT-JT综合征。作者称这是首例将18F-氟胆碱PET/CT用于HPT-JT综合征伴活动性颌骨病变评估与管理的报道。

要点

  • 18F-氟胆碱PET/CT可同时显示功能亢进的甲状旁腺与颌骨骨化纤维瘤。
  • 常规99mTc-MIBI显像不能明确时,18F-氟胆碱PET/CT可提供关键定位信息。
  • 基因检测证实CDC73突变支持HPT-JT综合征诊断。

核心结论

  • 18F-氟胆碱PET/CT在此例HPT-JT综合征中成功定位功能亢进的甲状旁腺并显示活动性上颌骨骨化纤维瘤,为手术规划提供关键信息。
  • 作者认为18F-氟胆碱PET/CT可能成为HPT-JT综合征长期疾病监测的有用诊断工具。

研究设计与样本

  • 单例病例报告:15岁男性,表现为严重高钙血症、PTH血清水平升高及颌骨骨化纤维瘤切除史。

主要发现

  • 18F-氟胆碱PET/CT识别出功能亢进的甲状旁腺,后续组织学诊断为甲状旁腺非典型腺瘤。
  • 18F-氟胆碱PET/CT同时识别出复发性上颌骨骨化纤维瘤。
  • 基因检测证实CDC73突变,确立HPT-JT综合征诊断。

关键数值与推荐

  • 99mTc-MIBI闪烁显像等标准影像学检查未能明确诊断。
  • 作者称18F-氟胆碱PET/CT敏感性优于常规影像学检查。

临床怎么用

  • 在pHPT患者常规影像学不能明确时,可考虑18F-氟胆碱PET/CT定位功能亢进的甲状旁腺。
  • 对HPT-JT综合征患者,18F-氟胆碱PET/CT可能有助于同时评估甲状旁腺与颌骨病变并辅助手术规划。

局限性

  • 本文为单例病例报告,结论需进一步研究验证。
  • 作者明确指出18F-氟胆碱PET/CT在HPT-JT综合征中的应用此前未见报道,需更多研究探讨其在遗传性内分泌疾病中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome is a rare autosomal dominant disorder caused by CDC73 gene mutations, predisposing individuals to primary hyperparathyroidism (pHPT), cemento-ossifying fibromas, and other neoplastic conditions. [18F]Fluorocholine PET/CT has emerged as a tool for localizing hyperfunctioning parathyroid glands in pHPT, but its application in HPT-JT syndrome remains unreported. CASE PRESENTATION: We describe the case of a 15-year-old male presenting with severe hypercalcemia, increased PTH serum levels, and a history of cemento-ossifying fibroma removal. Standard imaging, including [99mTc]Tc-MIBI scintigraphy, was inconclusive. [18F]Fluorocholine PET/CT successfully identified a hyperfunctioning parathyroid gland, identified as parathyroid atypical adenoma at subsequent histology, and a recurrent maxillary cemento-ossifying fibroma. Genetic testing confirmed a CDC73 mutation, leading to the diagnosis of HPT-JT syndrome. CONCLUSIONS: To our knowledge, this is the first reported case utilizing [18F]Fluorocholine PET/CT for the evaluation and management of HPT-JT syndrome with active presence of a maxillary cemento-ossifying fibroma. Given its superior sensitivity compared to conventional imaging, [18F]Fluorocholine PET/CT provided critical information for surgical planning and it might be a useful diagnostic tool for long-term disease monitoring. This case highlights the potential role of [18F]Fluorocholine PET/CT in detecting both parathyroid and jaw manifestations of HPT-JT syndrome, emphasizing the need for further research into its application in hereditary endocrine disorders.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Serani F, Lacognata CS, Torresan F, et al. [18F]Fluorocholine PET/CT in a 15-year-old patient suggested HPT-JT syndrome with active cemento-ossifying fibroma. EJNMMI Res. 2026. PMID: 41533239. doi:10.1186/s13550-025-01267-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。